Leukemic Phase of Non-Hodgkin Lymphoma

hematologic malignancy

Identifier: CI-CAN-00003025
Entity page: /cancer/leukemic-phase-of-non-hodgkin-lymphoma ↗
Edges: 77

Neighbours: 15 drugs10 trials
Drawn: 25 of 25 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Leukemic Phase of Non-Hodgkin Lymphoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 19show all (up to 200)
→ investigated in trials for	Mogamulizumabmonoclonal antibody 6 trials (3 active) · roll-up of the cancer and its descendants	—	—	Leukemic Phase of Non-Hodgkin Lymphoma	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Brentuximab Vedotin

Leukemic Phase of Non-Hodgkin Lymphoma studied in …STUDIED_INderived10 of 58show all (up to 200)
→ studied in	NCT04301076Phase 1 · recruiting Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL) · condition mapped ONTOLOGY_EXACT · 58 trials mapped (21 active)	—	—	Acute Adult T-Cell Leukemia/Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05944562Phase 1 · active not recruiting Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome · condition mapped ONTOLOGY_EXACT · 58 trials mapped (21 active)	—	—	Sezary Syndrome	1	Observed	clinicaltrials	graph →
→ studied in	NCT07003100recruiting A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab · condition mapped CURATED_BROADER · 58 trials mapped (21 active)	—	—	Sezary Syndrome	1	Observed	clinicaltrials	graph →
→ studied in	NCT04930653Phase 2 · recruiting Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 58 trials mapped (21 active)	—	—	Sezary Syndrome	1	Observed	clinicaltrials	graph →
→ studied in	NCT04904146recruiting Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome. · condition mapped ONTOLOGY_EXACT · 58 trials mapped (21 active)	—	—	Sezary Syndrome	1	Observed	clinicaltrials	graph →
→ studied in	NCT02978625Phase 2 · active not recruiting Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers · condition mapped ONTOLOGY_EXACT · 58 trials mapped (21 active)	—	—	Sezary Syndrome	1	Observed	clinicaltrials	graph →
→ studied in	NCT03011814Phase 1/Phase 2 · recruiting Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 58 trials mapped (21 active)	—	—	Sezary Syndrome	1	Observed	clinicaltrials	graph →
→ studied in	NCT05377827Phase 1 · suspended Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 58 trials mapped (21 active)	—	—	Sezary Syndrome	1	Observed	clinicaltrials	graph →
→ studied in	NCT04256018Phase 2 · recruiting Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome · condition mapped ONTOLOGY_EXACT · 58 trials mapped (21 active)	—	—	Sezary Syndrome	1	Observed	clinicaltrials	graph →
→ studied in	NCT03602157Phase 1 · active not recruiting Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL · condition mapped ONTOLOGY_EXACT · 58 trials mapped (21 active)	—	—	Sezary Syndrome	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains